Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial-Reference-Cited by-同舟云学术

Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial

Published:2021-10 Issue:10 Volume:21 Page:667-675
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Bird Sarah,Cairns David,Menzies Tom,Boyd Kevin,Davies Faith,Cook Gordon,Drayson Mark,Gregory Walter,Jenner Matthew,Jones John,Kaiser Martin,Owen Roger,Jackson Graham,Morgan Gareth,Pawlyn Charlotte

Funder

Myeloma UK

Cancer Research UK

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference22 articles.

1. Sex ratios and the risks of haematological malignancies;Cartwright;Br J Haematol,2002

2. Do women with cancer have better survival as compared to men after adjusting for staging distribution?;Oberaigner;Eur J Public Health,2011

3. Sex disparities in cancer mortality and survival;Cook;Cancer Epidemiol Biomarkers Prev,2011

4. Myeloma statistics,2019

5. Sex differences in cancer: epidemiology, genetics and therapy;Kim;Biomol Ther (Seoul),2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Strategies and Future Directions in Multiple Myeloma: Disease Overview and Pathophysiology, Conventional Treatments and Emerging Therapies, Challenges and Innovations in Management;European Journal of Medical and Health Research;2024-09-01

2. Prognostic frailty-based determinants of long-term mortality in older patients with newly diagnosed multiple myeloma;2024-08-20

3. Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT);American Journal of Hematology;2024-08-19

4. A Systematic Review of Modeling Approaches to Evaluate Treatments for Relapsed Refractory Multiple Myeloma: Critical Review and Considerations for Future Health Economic Models;PharmacoEconomics;2024-06-25

5. Immunophenotypic Expression and its Association with Prognostic Factors, Clinical Stages, and Clinical Profiles in Newly Diagnosed Patients with Plasma Cell Myeloma: Insights from Two Tertiary Care Centers;Biomedical Research and Therapy;2024-03-31